220502 – Emotra – PR – Emotra’s CFO appointed acting President

220427 – Emotra – PR – Communiqué Extraordinary shareholder meeting

220408 – Emotra – PR – Updated financial calendar 2022

220316 – Emotra – PR – Trading during the period until official listing

220311 – Emotra – PR – President has notified he will be stepping down

220307 – Emotra – PR – Comments on Spotlight’s decision to de-list

220221 – Emotra – PR – Plans for the period without official exchange trading

220218 – Emotra – PR – Listing review at Spotlight halted

220207-Emotra-PR-Publication-EUDOR_A

220206 – Emotra – PR – Resignation of two board members

220117 – Emotra – PR- Disclosure Notice and New Number of Shares

211214 – Emotra – PR – Result of subscription warrants series TO 2

211207 – Emotra – PR – Mangold Insight publishes analysis of Emotra AB

211126 – Emotra- PR – Emotra, exercise price for subscription warrants in TO2 series

211126 – Emotra- PR – Emotra finalizes its acquisition of NeuraMetrix

211125- Emotra – PR – Emotra insiders intend to exercise subscription warrants in TO2 2021 series

211125 – Emotra- PR – Dispute with Italian supplier finally resolved

211115 – Emotra- PM – Daniel Rudeklint appointed CFO

211027 – Emotra – PM – Publication of interim report postponed to November 29

211007 – PM – Emotra notifies that candidate for board is no longer available for appointment to the board of NeuraMetrix AB

210831 – PM – Emotra AB has reached conditional agreement to acquire NeuraMetrix

210707 – Emotra- PM – Emotra is granted patent protection in Canada

210709 – Emotra – PM – Emotra signs agreement with Kings College

20210617 – Emotra- PM – Freferential share issue for underwriters

20210615 – Emotra- PM – Rights issue outcome

210609 – Emotra – PM – Emotra signs agreement with NIMH

20210608 – Emotra- PM – CEO interview and analysis from Mangold Insight

210602 – Emotra – PM – Emotra participates at Småbolagsdagarna 2021

210422 – Emotra- PM – Board changes

210415 – Emotra – PM – Emotra signs Letter Of Intent with BLC

210215 – Emotra- PM – Publication in BMC Psychiatry

201229 – Emotra – PM – Emotra, overview for 2021

201221 – Emotra- PM – First relapse study accepted for publication in BMC Psychiatry

201120 – Emotra- PM – Notice of EGM

201026 – Emotra – PM – Result subscription warrants of TO 2020 series

201016 – Emotra – PM – CEO Daniel Poté intends to exercise subscription warrants

201009 – Emotra – PM – Emotra enters agreement to develop the german market

201008 – Emotra – PM – Chairman Claes Holmberg intends to convert subscription warrants

201007 – Emotra – PM – Emotra, postpones publication of 3q report

201007 – Emotra – PM – Emotra, exercise price for subscription warrants in to 2020

200929 – Emotra – PM – Emotra, update on research

2000908 – Emotra- PM – Presentation at Aktiespararna’s shareholder day

200821 – Emotra – PM – Emotra signs collaboration agreement with psychiatric clinic at Örebro university hospital

200603 – Emotra- PM – Communique from AGM

200528 – Emotra – PM – Claim form served concerning debt

200526 – Emotra – PM – Emotra is collaborating with RISE for EDOR test

200507 – Emotra – PM – Effects of Covid-19 on Emotra’s operations

200406 – Emotra- PM -Trade in subscription warrants on spotlight stock market

200403 – Emotra- PM – Final day for tradel in BTU

200326 – Emotra- PM – Liquidity guarantor

200325 – Emotra – PM – Emotra signs collaboration agreement for clinical studies

200323 – Emotra- PM – Results of the rights issue

200309 – Emotra – PM – Emotra close to sealing collaboration agreement for clinical studies

200224 – Emotra- PM – Issue resolution FINAL_Correction_clean

200226 – Emotra – PM – Correction regarding our Q1 2020 report

200224 – Emotra- PM – Issue resolution

200212 – Emotra – PM – Emotra comments on share trade volumes and the share price rise

200206 – Emotra – PM – Emotra signs agreement for research collaboration

191127 – Emotra -PM – Lectures

190515 – Emotra- PM – Communiqué from AGM

190509- Emotra – PM – EDOR identifies patients with a higher risk of depression relapse

190503- Emotra – PM – patent approved in USA

190424 – Emotra- PM – Documents for AGM

190415 – Emotra- PM – Notice AGM

190305 – Emotra – PM – Comments on communication from individual researcher

181120- Emotra – PM – Important discoveries in research

181116- Emotra – PM – Letter of intent with psychiatric hospital

181101 – Emotra- PM – Issue resolution

181024 – Emotra- PM – Emotra changes CEO and Chairman

181018 – Emotra- PM – Introduction at German hospital

180904- Emotra – PM – New publication demonstrates the strength of EDOR tests

180730- Emotra – PM – Patent approved in Japan

180509 – Emotra- PM – Communiqué AGM

180507 – Emotra – PM- Agreement with Univeristy in Warsaw

180418 – Emotra- PM – Documents for AGM

180409 – Emotra- PM – Notice AGM

180309 – Emotra- PM – First contract signed

180223- Year-end report 2017

171130 – Emotra – PM- Changed training seminar planning

170718 – Emotra – Final day for trading in PSS

170703 – Emotra – Communiqué from AGM

170626 – Emotra – Flagging notification

170626 – Emotra – Results of the rights issue

70609 – Emotra – PM – Documents for AGM

170607- Emotra- Subscription period begun

170531 – Emotra – AGM notice

170531 – Emotra – Publication of memorandum

170526 – Emotra – Issue resolution

170519 – Emotra- PM – EGM bulletin

170515 – PM – Emotra announces launch shortly_EN

170503 – Emotra – Notice of EGM_EN

170503 – Emotra – Board proposes authorisation

170331 – Emotra – PM – Consensus meeting supports EDOR launch plans

170313 – Emotra – PM – Horizon 2020- application rejected

161128-emotra-pm-horizon-2020-application-rejected-en

160727 – Emotra – PM – Analysis of the baseline material in EUDOR-A

160427 – Emotra – PM – AGM bulletin

160405- Emotra- PM- Documents for AGM

160323- Emotra- PM- Notice of AGM

160311 – Emotra – PM – First stage of study completed

160121 – Emotra – PM – EU grants Emotra financial support

151026 – Emotra – PM – Last day for trading in PSS

151012 – Emotra – PM – Flagging notice

151012- Emotra – PM – Results of new share issue

150923 – Emotra – PM – The subscription period starts

150922- Emotra – PM – PRV Approves Emotra’s Patent Application

150921- Emotra – PM – Meeting in Rome

150910 – Emotra – PM – Resolution on share issue

150901 – Emotra – PM – Communiqué from extraordinary general meeting

150710- Emotra – PM – EDOR presentation in the US

150512- Emotra – PM – EU H2020 application denied

150428 – Emotra – PM – AGM bulletin

150402- Emotra- PM- Annual report 2014

150401- Emotra – PM – EDOR at Vienna convention

150327- Emotra – PM – International conventions

150327- Emotra- PM- Notice of Emotra’s AGM

150318- Emotra – PM – EU H2020 application

150213- Emotra – PM – EGM approved share split

150115- Emotra – PM – Notice of EGM

141217- Emotra – PM – EU card granted by Västra Götalandsregionen-en

141024- Emotra – PM – Honourable appointment for Lars-Håkan Thorell

140930- Emotra – PM – Agreement with researchers

140919- Emotra – PR – Ethics committee approval

140813- Emotra – PR – International symposium 2015

140609- Emotra – PM – Development project completed

140429- Emotra – PM from AGM

140415- Emotra – PM – Kick-off meeting in Rome

140401- Emotra – PM -Agreement with clinic in Rostock

140328- Emotra – PM – Notice AGM

140324- Emotra – PM -Agreement with clinic in Lisbon

140324- Emotra – PM – Kick-off meeting in Rome

140320- Emotra – PM -Agreement with clinic in Tübingen

140317- Emotra – PM – Agreement with two more clinics

140312-Emotra- PM- CE marking

140307- Emotra – PM – Agreement with three clinics

140217- Emotra – PM – Agreement with Swedish hospitals

140212- Emotra – PM – Agreement with National Institute of Psychiatry, Budapest

140206- Emotra – PM – Agreement with University of Cluj-Napoca

140203 – Emotra – PR – Subscription

140123- Emotra – PM – Agreements with universities of Bari and Piemonte

140123 – Emotra – PR – Agreement with University of Rome

140117 – Emotra – PR – Agreement with University of Genoa

140116 – Emotra – PM – New share issue begins

140110 – Emotra – PM – Agreement with EPA-SS

140108- Emotra – PM – EGM Bulletin

131227- Emotra- PM- Agreement with opinion leader

131219_2 – Emotra – PM – Rights issue decission

131219 – Emotra – PM – Notice of extraordinary general meeting

Press release October 31 2013

Press release October 8 2013

Press release October 1 2013

Press release September 18 2013

Press release September 13 2013

Press release September 11 2013

Press release August 28 2013

Press release August 27 2013

Press release August 15 2013

Press release June 27 2013

Press release May 28 2013

Pressmeddelande från Emotra 20130423

Pressmeddelande från Emotra 20130328

Pressmeddelande från Emotra 20130315

Pressmeddelande från Emotra 20130225

Pressmeddelande fran Emotra 20130220